ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Stroke, Cerebral Ischemia, Brain Infarction
About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Fibrinogen, Reperfusion, Thrombolysis
Eligibility Criteria
Inclusion Criteria: Acute, ischemic stroke with first symptoms within 6 hours of beginning treatment Baseline NIHSS > 5 Exclusion Criteria: No intracranial, extravascular blood on CT Hypertension (systolic > 185; diastolic > 105) Baseline fibrinogen level < 100 mg/dL Thrombocytopenia (< 100,000 / mm3) Recent (< 3 days) or anticipated (< 5 days) use of a thrombolytic agent Recent (< 14 days) or anticipated surgery
Sites / Locations
- Enloe Medical Center
- UCSF-Fresno
- Sherry Braheny MD - A Prof. Corporation
- Mercy General Hospital
- Los Robles Hospital and Medical Center
- Yale University School of Medicine
- Manatee Memorial Hospital
- Bradenton Research Center
- Melbourne Internal Medicine Associates
- Collier Neurologic Specialists
- Naples Community Hospital
- Suncoast Neuroscience Associates
- Joan Glancy Memorial Hospital
- Joan Glancy Memorial Hospital
- Gwinnett Medical Center
- Dekalb Medical Center-Hillandale
- Candler Hospital
- St. Joseph's Hospital
- OSF Saint Joseph Medical Center
- Bromenn Regional Medical Center
- Bronson Methodist Hospital
- Saint Luke's Hospital Mid America Brain and Stroke Institute
- Research Medical Center
- St. Louis University Hospital - Dept of Neurology
- Nevada Neuroscience Institute at Sunrise
- Jersey Shore University Medical Center
- Neuroscience Institute St Francis Medical Center
- Lutheran Medical Center
- Five Towns Neuroscience Research
- Aultman Hospital
- Charles F. Kettering Memorial Hospital
- Doylestown Hospital
- Lancaster General Hospital
- Hahenmann University Hospital
- AnMed Health
- Chattanooga Center for Neurologic Research
- Overlake Hospital Medical Center
- Providence St. Peter Hospital
- CAMC Memorial Hospital
- St Vincent's Hospital
- Gold Coast Hospital
- Moash Medical Center Dept of Neurology
- Royal Melbourne Hospital
- Alfred Hospital Research - Melbourne
- Concord Hospital Neuroscience Department
- Medical University of Affairs
- Neurologische Intensivstation
- University Hospital Hradec Kralove Neurological Department
- PalackyUniversity Faculty of Medicine and Dentistry and University Hospital
- Vitkovice Hospital Department of Neurology
- Regional Hospital Pardubice
- General University Hospital Clinic of Neurology-Stroke Center
- Thomayer's Faculty Clinic of Neurology
- University Hospital Motol Department of Neurology
- Barzilai Medical Center
- Soroka Medical Center Dept of Neurology Ben-Gurion Univ of the Negev
- Bnei-Zion Medical Center
- Rambam Medical Center Dept. of Neurology
- Wolfson Medical Center
- Hadassah Ein-Karem Medical Center
- Western Galilee Hospital Neurology Dept
- Rabin Medical Center Golda Campus (Hasharon)
- Tel-Aviv Medical Center
- Chaim Sheba Medical Center Neurology Dept
- Auckland City Hospital
- Cristchurch Hospitial
- Samodzielny Publiczny Szpital Kliniczny nr1, Akademickie Centrum
- Katedra i Klinika Neurologii, Wieku Podesziego
- Klinika Neurologii Akademii Medycznej w Lublinie
- Centrum Medycne HCP sp.zo.o Dept. Neurlogy
- Institute for Psychiatry and Neurology 2nd Neurology Dept.
- City Clinical Hospital MU KGB Nr. 40
- Jaroslav Regional Clinical Hospital State Institution of Healthcare
- State Multiregional Clinical Diagnostical GU MKDZ
- Central clinical Hospital of the President of the Russian Federation
- Burdenko Central Military Clinical Hospital of Ministry of Defense of Russia
- Municipal Institution of Health City Clinical Hospital No. 1
- Hospital Baranov
- Railway Hospital at Rostov-Glavnity of OJSC "Russian Railways"
- City Hospital Nr. 1 of Pirogov
- State Medical University named after IP Pavlov Leo Tolstoj
- Multiprofile City Clinic No. 2
- City Clinic Neurology N2 of Marinski Hospital
- Fakultna nemocnica s poliklinikou Bratislava
- Vseobecna nemocnica s polokliniknikou Levoca a.s.
- Martinska fakultna nemocnica
- Fakultna nemocnica Nitra
- Fakultna nemocnica Nitra
- Nemocnica s poliklinikou Spisska
- Fakultna nemocnica s poliklinikou J.A. Reimana
- Fakultna nemocnica Trnava
- Clinical Projects Research
- Centre Hospitalier universitaire Vaudois, Dept. of Neurology
- Universitatsspital Zurich
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Intravenous ancrod
Intravenous Placebo
Intravenous ancrod infused at a rate of 0.167 IU/kg/hr (0.6 mL/kg/hr) for 2 or 3 hours depending on the pretreatment fibrinogen level.
Intravenous placebo at a rate of 0.6 mL/kg/hr for 2 or 3 hours depending on the pretreatment fibrinogen level.